For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as ...

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among ...

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; ...

Walking the woods shows me how to release fear, grief, and expectations, trusting that letting go nourishes growth, ...

Dr. Joshua Sabari spoke with advocate Chris Conneran on his journey from caregiver to champion for KRAS-mutant cancer patients and families.

Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.

Viewing identity through the lens of the seasons underscores the fluid, evolving nature of who we are. Just as the seasons ...

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients.

This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.

That is what standing up to cancer means to me: not just surviving, but living fully, deeply, and purposefully, showing the ...

For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo ...